Search results for "cancer diagnosis"

The IMMULITE 2000/2000 XPi TSI assay detects thyroid stimulating antibodies, the specific cause of GD pathology, with a clinical sensitivity and specificity of 98.6% and 98.5% respectively. With a 65-minute total assay time and ready-to-use, stable reagents, the use of this assay can make the differential diagnosis of GD faster and easier, allowing patients to be diagnosed and treated sooner.

Through a combination of advanced imaging and novel artificial intelligence, latest diagnostic system for cervical cancer screening can help more accurately detect disease, improve workflow and enhance patient care

Elucidating the roles of cancer associated fibroblasts in modulating the tumor microenvironment

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research

Nuvec is N4 Pharma’s proprietary gene delivery system being developed to safely and effectively transport RNA therapies for cancer and other diseases

Both REQORSA alone and in combination with LUMAKRAS demonstrated robust anti-tumor effects in Ras inhibitor resistant non-small cell lung cancer

Learn about remarkable advances in sepsis diagnosis and monitoring over the past 25 years as we highlight some of the most notable breakthroughs.

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

Dr. Claudia Maria A. Pinna is recognized for her pioneering work in precision medicine and cancer research using 3D patient-derived organoid models

Used by laboratories carrying out nucleic acid-based testing, PrimeStore MTM ensures the transport and testing process is streamlined and safe

With the QIAGEN nanoplate-based dPCR system, clinical scientists find better ways to diagnose invasive fungal disease and side-step antifungal therapy resistance

Fast and Accurate Diagnosis of Chlamydia and Gonorrhea

Talk to focus on the spinout journey from drug repurposing to clinical trials for diagnosing and treating Alzheimer’s disease

150cm² available growth area Manufactured from optically clear virgin polystyrene Treated for optimal cell attachment Printed with lot numbers for ease in traceability 100% integrity tested Sterile Nonpyrogenic